Alkem Laboratories to meet Tata, Mahindra Manulife investors this week

Alkem Laboratories Ltd. will engage in two in-person meetings with institutional investors on December 18, 2025. The Mumbai-based pharmaceutical company will first meet with Tata Mutual Fund, followed by a separate engagement with Mahindra Manulife on the same day. Both meetings are categorized as "One-on-One meet" sessions.

The company provided this intimation to both the BSE Limited and the National Stock Exchange of India Limited. The announcement, signed by Manish Narang, president - legal, company secretary & compliance officer, emphasizes that the schedule is subject to change based on investor or company exigencies.

These meetings are conducted in accordance with relevant provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Alkem Laboratories' registered office is at Alkem House, Senapati Bapat Marg, Lower Parel (West), Mumbai - 400 013, Maharashtra, India.